SIMCERE Trademark

Trademark Overview


On Monday, September 2, 2019, a trademark application was filed for SIMCERE with the United States Patent and Trademark Office. The USPTO has given the SIMCERE trademark a serial number of 79276391. The federal status of this trademark filing is REGISTERED as of Tuesday, November 24, 2020. This trademark is owned by Jiangsu Simcere Pharmaceutical Co., Ltd. The SIMCERE trademark is filed in the Pharmaceutical Products category with the following description:

Medicated troches; Medicines for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, musclo-skeletal disorders, infections, and bacterial infections, all for human purposes; [ Biochemicial ] * Biochemical * drug for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, musculo-skeletal disorders, infections, and bacterial infections, all for human purposes; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical purposes; Active pharm...
simcere

General Information


Serial Number79276391
Word MarkSIMCERE
Filing DateMonday, September 2, 2019
Status700 - REGISTERED
Status DateTuesday, November 24, 2020
Registration Number6202775
Registration DateTuesday, November 24, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements


Description of MarkThe mark consists of a design of a running person composed of geometric figures, displayed within a flag-like rectangular design and the wording "SIMCERE" to the right.
Certificate of Correction for Registration In the statement, " International Class 5 " is corrected per the restriction notice dated 7/6/2023
Goods and ServicesMedicated troches; Medicines for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, musclo-skeletal disorders, infections, and bacterial infections, all for human purposes; [ Biochemicial ] * Biochemical * drug for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, musculo-skeletal disorders, infections, and bacterial infections, all for human purposes; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical purposes; Active pharmaceutical ingredients, namely, extracts of hops for pharmaceutical purposes, eucalyptus for pharmaceutical purposes, mint for pharmaceutical purposes, malt for pharmaceutical purposes, pepsins for pharmaceutical purposes,thymol for pharmaceutical purposes,turpentine for pharmaceutical purposes, flaxseed for pharmaceutical purposes, ferments for pharmaceutical purposes, cytostatics for pharmaceutical purposes, balms for pharmaceutical purposes, digestives for pharmaceutical purposes, iodine for pharmaceutical purposes, alcohol for pharmaceutical purposes, starch for pharmaceutical purposes; Pharmaceutical preparations for injection for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, musclo-skeletal disorders, infections, and bacterial infections, all for human purposes; Chinese patent medicines for the prevention and treatment of cancer, central nervous system diseases, autoimmune diseases, cardiovascular diseases, gastrointestinal diseases, lung disease, osteoporosis, rickets, chondropathy, renal osteopathy, hypoparathyroidism, dental diseases, hyperlipidemia, depression, hypercholesteremia, kidney diseases, and, musclo-skeletal disorders, infections, and bacterial infections, all for human purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJiangsu Simcere Pharmaceutical Co., Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameJiangsu Simcere Pharmaceutical Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameJiangsu Simcere Pharmaceutical Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Monday, April 8, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, September 12, 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Wednesday, August 16, 2023CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Tuesday, August 8, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 8, 2023CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, August 8, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, July 9, 2023CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, October 27, 2021NEW REPRESENTATIVE AT IB RECEIVED
Sunday, March 21, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 26, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 26, 2021FINAL DISPOSITION PROCESSED
Wednesday, February 24, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 24, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 3, 2020EXAMINER'S AMENDMENT ENTERED
Monday, August 3, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 3, 2020EXAMINERS AMENDMENT E-MAILED
Monday, August 3, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, July 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 23, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 23, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 13, 2020REFUSAL PROCESSED BY IB
Saturday, February 22, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 22, 2020REFUSAL PROCESSED BY MPU
Tuesday, January 28, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 27, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 21, 2020APPLICATION FILING RECEIPT MAILED
Friday, January 17, 2020ASSIGNED TO EXAMINER
Friday, January 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 16, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB